PFIZER - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

📉 Swing Trade Analysis: Pfizer Ltd. (PFIZER)

Swing Trade Rating: 2.7

⚠️ Technical Challenges

Weak Momentum

RSI at 37.8: Suggests bearish sentiment, skimming oversold levels.

MACD at −72.3: Strongly negative, indicating persistent downward pressure.

Volume Concerns

Current volume is nearly half the 1-week average — hints at low trader interest.

Price Action

Trading below 50 DMA (₹5,353), hovering just above 200 DMA (₹4,988) — not strong technically.

🔍 Fundamental Snapshot

Valuation Red Flag

P/E ratio of 158 vs. industry average of 34.0: Heavily overvalued relative to peers.

Missing PEG ratio makes growth justification difficult.

Strong Returns & Clean Balance Sheet

ROCE at 27.2%, ROE at 19.8% — respectable efficiency and profitability.

Debt to equity at 0.00: No leverage risk — a big plus.

EPS of ₹100: Solid earnings base.

Quarterly PAT Data Missing: Harder to assess recent earnings momentum.

📈 Entry Strategy

Entry Zone: ₹5,100–₹5,200

Price near 200 DMA could offer support.

Entry should only be considered after MACD flattens and RSI rises above 40 — ideally with a volume surge.

🚪 Exit Strategy (If Already Holding)

Target Range: ₹5,400–₹5,500

A bounce toward the 50 DMA would be a logical short-term exit.

Stop-Loss: ₹5,000

Slightly below current price and near support — a prudent risk cap.

Pfizer’s fundamentals are sturdy, but its high valuation and weak technicals dilute swing potential. It’s currently more suited for watchlist status than an active trade. If you’re hunting for defensive plays with better momentum, I can scout others for you. 🧐💡

Edit in a page